Furthermore, the crosstalk between the EGFR and programmed cell death protein 1/programmed cell death ligand 1 (PD-1/PD-L1) is observed in the NSCLC, which downregulates T cell signaling and helps the tumor evade immune surveillance [12]. The gene discussed is EGFR; the disease is neoplasm.